Skip to main content
Search
Search
About Angelman Syndrome
About FAST
For Researchers
Welcome
Apply for a Grant
Grant Application Process
FAST-Funded Research
For Pharma
Welcome
The Pharma-Research-Community Hub
FAST Ventures
Resources
For Families & Caregivers
Welcome
Newly Diagnosed?
Understanding AS Genetics and Genotypes
Treatment & Trials
Get Involved
Resources for Caregivers
For Donors & Investors
Welcome
Ways to Give
Cure Angelman Now (CAN)
FAST Ventures
Contact Us
Donate
Donate
Menu
Accessibility Statement
We Strive to Make This Site Open to Everyone
Angelman Syndrome News
05/16/2024
Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome
05/14/2024
Purdue WellCast Study
05/14/2024
Skating Angels host their Annual Hockey Tournament
05/14/2024
Understanding Clinical Outcome Assessments (COAs) Used in Clinical Trials
04/30/2024
Newly published article on research exploring the epigenetic landscape of Angelman syndrome
04/30/2024
2023 CAN Grand Prize Trip
04/22/2024
FAST’s Genetic Services & Education
04/17/2024
April 17, 2024 Newsletter | What to Know
04/15/2024
Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment...
04/01/2024
Dr. Cesar Ochoa-Lubinoff
04/01/2024
Welcoming FAST Germany
04/01/2024
FAST LatAm Updates
03/19/2024
Inaugural Angelman Syndrome Congressional Advocacy Day Round-Up
03/19/2024
Global Spotlight: Heather Brady
03/07/2024
Family Advocates Urge Congress’ Support During Inaugural Angelman Syndrome Congressional Advocacy Day
03/05/2024
MENA Angelman Symposium Q&A
03/05/2024
New FAST-TRAC grant collaboration with Dr. Alvin Huang
03/05/2024
How Clinical Trials Work
02/29/2024
A Message from Lauren Black
02/21/2024
International Angelman Day 2024 Round-Up
05/16/2024
Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome
05/14/2024
Purdue WellCast Study
05/14/2024
Skating Angels host their Annual Hockey Tournament
05/14/2024
Understanding Clinical Outcome Assessments (COAs) Used in Clinical Trials
04/30/2024
Newly published article on research exploring the epigenetic landscape of Angelman syndrome
04/30/2024
2023 CAN Grand Prize Trip
04/22/2024
FAST’s Genetic Services & Education
04/17/2024
April 17, 2024 Newsletter | What to Know
04/15/2024
Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment...
04/01/2024
Dr. Cesar Ochoa-Lubinoff
04/01/2024
Welcoming FAST Germany
04/01/2024
FAST LatAm Updates
03/19/2024
Inaugural Angelman Syndrome Congressional Advocacy Day Round-Up
03/19/2024
Global Spotlight: Heather Brady
03/07/2024
Family Advocates Urge Congress’ Support During Inaugural Angelman Syndrome Congressional Advocacy Day
03/05/2024
MENA Angelman Symposium Q&A
03/05/2024
New FAST-TRAC grant collaboration with Dr. Alvin Huang
03/05/2024
How Clinical Trials Work
02/29/2024
A Message from Lauren Black
02/21/2024
International Angelman Day 2024 Round-Up
